Search

everythinglearnresearchcommunity

for

Search:↓

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Metformin helps manage PCOS by improving fertility and is safe for pregnancy, especially when combined with certain treatments.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Metformin helps reduce PCOS-related infertility by improving insulin sensitivity and inducing ovulation.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

SHBG may be a useful early indicator and treatment target for PCOS.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.